【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Leukemia Overview 8
3 Products under Development 9
3.1 Leukemia – Pipeline Products by Stage of Development 9
3.2 Leukemia – Pipeline Products by Territory 10
3.3 Leukemia – Pipeline Products by Regulatory Path 11
3.4 Leukemia – Pipeline Products by Estimated Approval Date 12
4 Leukemia – Pipeline Products under Development by Companies 13
4.1 Leukemia Companies – Pipeline Products by Stage of Development 13
4.2 Leukemia – Pipeline Products by Stage of Development 15
5 Leukemia Companies and Product Overview 18
5.1 Abbott Diagnostics Company Overview 18
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Acobiom Company Overview 22
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Adaptive Biotechnologies Corporation Company Overview 23
5.3.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 BioSense Technologies, Inc. Company Overview 24
5.4.1 BioSense Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Cancer Genetics, Inc. Company Overview 25
5.5.1 Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Cepheid Company Overview 27
5.6.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Di.V.A.L Toscana srl Company Overview 29
5.7.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Diagnovus, LLC Company Overview 30
5.8.1 Diagnovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 DiaSorin S.p.A Company Overview 31
5.9.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Eutropics Pharmaceuticals, Inc. Company Overview 37
5.10.1 Eutropics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 Gendiag Company Overview 41
5.11.1 Gendiag Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Health Discovery Corporation Company Overview 42
5.12.1 Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 InVivoScribe Technologies, Inc. Company Overview 44
5.13.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 IV Diagnostics, Inc. Company Overview 46
5.14.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Jaden BioScience Inc. Company Overview 47
5.15.1 Jaden BioScience Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 MolecularMD, Corp. Company Overview 48
5.16.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Monoquant Pty. Ltd. Company Overview 49
5.17.1 Monoquant Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Nodality, Inc. Company Overview 50
5.18.1 Nodality, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 NuCana BioMed Limited Company Overview 51
5.19.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Nuclea Biotechnologies Inc. Company Overview 59
5.20.1 Nuclea Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.21 OncoVista Innovative Therapies, Inc. Company Overview 62
5.21.1 OncoVista Innovative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Qiagen N.V. Company Overview 64
5.22.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 64
5.23 Siemens Healthcare Diagnostics Inc. Company Overview 66
5.23.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Skyline Diagnostics BV Company Overview 68
5.24.1 Skyline Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 68
5.25 St. Jude Children’s Research Hospital, Inc. Company Overview 70
5.25.1 St. Jude Children’s Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.26 The Feinstein Institute for Medical Research Company Overview 73
5.26.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 University of Barcelona Company Overview 75
5.27.1 University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview 75
5.28 University of California, San Diego Company Overview 76
5.28.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 University of Missouri Company Overview 78
5.29.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 Vela Diagnostics Company Overview 79
5.30.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Vivia Biotech, S.L. Company Overview 80
5.31.1 Vivia Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Wake Forest Baptist Medical Center Company Overview 83
5.32.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Xiamen Zeesan Biotech Co.,Ltd Company Overview 85
5.33.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
6 Leukemia- Recent Developments 87
7 Appendix 90
7.1 Methodology 90
7.2 About GlobalData 92
7.3 Contact Us 93
7.4 Disclaimer 93
【レポート販売概要】
■ タイトル：世界における白血病検査製品のパイプライン動向2015■ 英文：Leukemia - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0073EPD
■ 調査対象地域：グローバル
- 世界の酪農食品（乳製品）市場のM&A動向（2014年7月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global dairy food market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the partn …
- 非熱的殺菌の世界市場予測（～2023年）“The non-thermal pasteurization market is projected to grow at a CAGR of 19.8%”The non-thermal pasteurization market is estimated at USD 1.1 billion in 2018 and is projected to grow at a CAGR of 19.8%, to reach USD 2.7 billion by 2023. Non-thermal pasteurization technologies have been proven to reduce food processing time and energy consumption as compared to traditional thermal technologies. This …
- 軟骨修復・軟骨再生の世界市場予測（～2021）：治療法別（軟骨細胞移植、増殖因子技術、組織スキャフォールド、無細胞コンポジット）、用途別、地域別The global cartilage repair market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of this market. However, high cost of therapy and unfavorable reimbursement scenario are the major facto …
- 世界のABS樹脂市場2015The Global ABS Resin Industry Report 2015 is a professional and in-depth study on the current state of the ABS Resin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The ABS Resin market analysis is provided for the international markets including development trends, competitive landscape analysis, and …
- PTFEメンブレンの世界市場予測（～2021）：疎水性メンブレン、親水性メンブレンThe PTFE membrane market is projected to reach USD 2.32 Billion by 2021, at a CAGR of 7.7% from 2016 to 2021. The PTFE membrane market has witnessed high growth in the recent years, and this growth is projected to continue in the near future, owing to the increase in the demand for PTFE membrane in the medical & pharmaceutical, industrial filtration, water & wastewater treatment applications. Incr …
- 超高強度鋼の世界市場予測（～2022年）：二相、複合相、多相、マルテンサイト、変態誘起塑性The ultra-high strength steel market is estimated to be USD 7.96 Billion in 2017 and is projected to reach USD 11.35 Billion by 2022, at a CAGR of 7.35% from 2017 to 2022. High consumption of ultra-high strength steels in automotive, aerospace & defense, and construction industries is one of the most significant factors contributing to the growth of the ultra-high strength steel market. Based on t …
- 電気自動車（EV）ポリマーの世界市場展望2017-2026According to Stratistics MRC, the Global Electric Vehicle (Car) Polymers Market is accounted for $1.48 billion in 2017 and is expected to reach $123.58 billion by 2026 growing at a CAGR of 61.5%. Factors such as rising demand for electric vehicles among the emerging economies of Asia Pacific region, rapid rise in government regulations and development of charging infrastructure are fueling the mar …
- 世界の航空宇宙用複合材料市場動向（2012-2016）TechNavio’s analysts forecast the Global Aerospace Composites market to reach US$3.95 billion by 2016. One of the key factors contributing to this market growth is the increased adoption of composites in aircraft design. The Global Aerospace Composites market has also been witnessing strong demand in general aviation. However, complex regulatory requirements pose the biggest challenge in the marke …
- 病院用物流ロボットの世界市場2018-2022About Hospital Logistics Robots Hospital logistics robots comprise autonomous guided vehicles (AGVs) and mobile robot platforms. These are used for managing the flow of goods such as laboratory samples, food, pharmaceuticals, environmental waste, and laundry inside hospital premises. Technavio’s analysts forecast the global hospital logistics robots market to grow at a CAGR of 15.48% during the pe …
- 特殊油脂および油の世界市場予測（～2022）：油種類別（パーム、大豆、菜種、ココナッツ、綿実）、脂肪種類別（チョコレート用油脂(CBE)、ココアバター代替脂(CBR、CBS、CBI)、乳脂肪代替品）、用途別（チョコレート＆製菓、パン、乳製品）、形態別、地域別“Specialty fats market is projected to grow at a CAGR of 9.7%, whereas the specialty oils market is projected to grow at a CAGR of 6.4% in terms of value.”The specialty fats market is projected to grow at a CAGR of 9.7% to reach USD 3.45 billion and specialty oils market is projected to grow at a CAGR of 6.4% to reach 20.15 billion by 2022. The demand for specialty fats & oils is projected to grow …
- MDU Resources Group, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013MDU Resources Group, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary MDU Resources Group, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 世界の上位10か国におけるアウトバウンドツーリズム市場：観光客数、支出動向Summary Top 10 Outbound Tourism Markets, Trips and Spending per Country To 2018 provides detailed information on the top 10 outbound tourism markets globally. This report analyzes market data and provides a better understanding of tourism flows and tourist expenditure. Key Findings - Mexico is the leading tourist destination for Americans, accounting for 30.4% of total international departures in …
- Engerix-B（B型肝炎ワクチン）市場動向（～2022）Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related …
- 企業向けクラウドサービスの世界市場：SaaS、IaaS、PaaSAbout Enterprise Cloud Services Enterprise cloud services involve delivery of cloud computing services that include software, infrastructure, and platform services to individual businesses and enterprises in a more secured environment. Business enterprises worldwide are rapidly adopting cloud computing technologies to reduce their costs, manage enterprise IT infrastructure and business processes e …
- エネルギー回収式換気装置の世界市場：プレート熱交換、熱パイプ熱交換、回転式熱交換、ランアラウンドコイルThe global energy recovery ventilator market is projected to reach USD 3.39 Billion by 2021, at a CAGR of 11.4% between 2016 and 2021. This growth is mainly attributed to the increasing demand of energy recovery ventilators from the end-use segments of commercial and residential ventilation. Increasing demand for fresh air and the need to reduce indoor pollutants drives the growth of this market. …
